PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.07%
Negative net income growth while AVGO stands at 100.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.21%
D&A growth well above AVGO's 3.45%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
36.36%
Some yoy growth while AVGO is negative at -100.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-10.34%
Both cut yoy SBC, with AVGO at -4.85%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
738.30%
Well above AVGO's 100.00% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
194.70%
AR growth while AVGO is negative at -70.18%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-21.58%
Negative yoy inventory while AVGO is 737.50%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
569.23%
A yoy AP increase while AVGO is negative at -122.79%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
7.12%
Lower 'other working capital' growth vs. AVGO's 100.00%. David Dodd would see fewer unexpected short-term demands on cash.
103.13%
Lower 'other non-cash' growth vs. AVGO's 2198.75%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
15.36%
Operating cash flow growth 1.25-1.5x AVGO's 12.92%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
9.42%
Lower CapEx growth vs. AVGO's 29.07%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
50.73%
Purchases well above AVGO's 58.90%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-100.00%
We reduce yoy sales while AVGO is 300.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
10542.31%
We have some outflow growth while AVGO is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
226.08%
We have mild expansions while AVGO is negative at -104.07%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
90.85%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-25.64%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-68.87%
We cut yoy buybacks while AVGO is 10.81%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.